KLIFO - Key Persons
Alejandra Mørk, PhD and MSc Pharm, has more than 30 years of experience in drug development and life cycle management. In 2008, Alejandra acquired KLIFO to build an international end to end drug development consultancy. From 2008 to 2023 she was CEO of the company. Prior to acquiring KLIFO, Alejandra spent 18 years at Nycomed Pharma in various leadership positions in Project Management, Clinical Development and Regulatory Affairs and was overall responsible for Drug Development.
Anne has more than 30 years' experience in pharmaceutical product development and Quality Assurance. For the past more than 20 years she has worked as a QP delegate. She is an expert in packaging and labelling for clinical trials and has vast experience with design and maintenance of Quality Management Systems. Anne joined KLIFO in 2017.
Anne Tingsgård holds a Master of Pharmacy degree and joined KLIFO in September 2014. She has more than 30 years' regulatory affairs experience from both big pharma and private consulting, including two years as CEO and COO in A-consult.
Christina Vinum joined KLIFO in February 2011 as Senior Clinical Trial Supply Coordinator and became Director of Clinical Trial Supply in January 2012 and VP: Clinical Trial Supply in 2014. Christina has more than 15 years experience with clinical trial supplies, first at Nycomed from 2001 as Clinical Trial Supply Coordinator and, from January 2009, as Head of Clinical Supply for Nycomed CTS departments in Denmark and Germany.
Job Titles:
- Director, Business Development
Dr. Christoph Kapitza joined KLIFO on 1 August 2022 and brings more than 25 years of research experience in the development of drugs, devices and drug-device combination products. He has a proven track record of successfully executing drug development strategies and has held several leadership positions in the pharma industry. Dr. Kapitza has been Principle Investigator in approx. 90 early and later phase studies, and he has been a consultant in relation to clinical development plans (phase I through to post-marketing studies) for several top global pharma companies.
Hanne holds a Ph.D. in biopharmaceutics and has more than 25 years of pharma industry experience within pharmaceutical product development, business development, project and vendor management, marketing and medical affairs. She joined KLIFO in January 2019 and prior to this she has held specialist and leadership positions in large pharmaceutical companies and in biotech.
Mette Kirstine was previously co-founder and CEO of 7TM Pharma A/S and has a broad international experience within biotech/life science covering business development and licensing, management and financing.
Mette has been appointed to numerous board positions both in private and public companies. Mette Kirstine Agger graduated as Biologist from the University of Copenhagen and has an MBA.
Niels Peder Nielsen is chairman, board member and investor in various technology companies. He also serves as senior advisor to Bain & Company. Niels Peder was deputy-CEO of the Novo Nordisk Foundation and before that a senior partner with Bain & Company.
Niels Peder has 25+ years of experience from professional services, and has worked extensively with clients in biotech and pharma, as well as with companies owned by private equity funds. Niels Peder holds an M.Sc from Massachusetts Institute of Technology, and a B.Sc from Copenhagen Business School.
Rafael Natanek is partner in the private equity team of Gilde Healthcare. He is involved with deal origination, deal execution and serves on the supervisory boards of investee companies. Rafael is co-responsible for portfolio management activities. Prior to joining Gilde Healthcare, Rafael was partner at Bain & Company in London, where he advised private equity funds on healthcare transactions, and pharmaceutical and medtech companies on strategy, organization and commercial issues. Prior to Bain, he was with McKinsey & Company. Rafael holds a MSc in Chemical Engineering from Lund Institute of Technology, and a MSc in Biomedicine from Lund University, Sweden. He did his thesis at UC Berkeley, California.
Rasmus Nelund joined KLIFO on 1 May 2023 and brings more than 20 years of experience as a leader in the international life sci ence industry. Prior to joining KLIFO, Rasmus worked 10 years as Corporate Vice President at NNIT A/S, where he led the company's strong international growth by supporting life sciences companies in their business transformation fuelled by technological change. He did this in senior leadership positions focusing on customer success, strategic execution, M&A and organisational development. Before joining NNIT, he co-founded the Clinical IT consulting company Herax A/S and served as CEO at Pipeline Biotech A/S, a CRO, specialised in preclinical research services.
Redmar Koene is an investment professional at Gilde Healthcare. He is involved with deal origination and deal execution and serves on the supervisory boards or equivalent of investee companies like KLIFO and Synexa (bioanalytical CRO). In addition, he worked with Symeres (drug discovery CRO) on strategy and M&A, as well as with several other companies on executing successful buy-and-build agenda's. Prior to joining Gilde Healthcare, he worked as investment professional at a Swiss-based investment company, investing in both listed as non-listed companies. Redmar has a MSc Finance and a MSc Accounting.
René Pedersen holds a Graduate Diploma degree and an MBA from Copenhagen Business School and joined KLIFO on 1 April 2023 as Chief Financial Officer.
René brings more than 25 years of international experience from leadership positions in life science and pharma consulting. Previously, René has worked as CFO at DanBred and as CFO and CVP at NNE. Between 1998 and 2016, René worked for Novo Nordisk in various leadership positions being responsible for finance and corporate strategies.
Job Titles:
- Senior Director HR and Lawyer
Rikke holds a MSc of Law and has more than 10 years of experience working as a lawyer at the Danish Chamber of Commerce advising companies within all aspects of employment law. She joined KLIFO in March 2021. Before that Rikke held a position as Nordic Head of HR at SOS international. Direct/mobile: +45 23 695 485 - Email: moc.ofilk@rekcneD.ekkiR
Job Titles:
- Managing Director
- Managing Director, KLIFO, Sweden
Sara joined KLIFO in December 2018 and has 15 years of experience from pharma, working with global project management within clinical trial management (phase 1-3) and clinical trial supplies. She is especially experienced within early clinical development (phase 1a-2a) and has managed trials within many different therapeutic areas in Europe, US and Asia.